Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis
A phase 2 trial registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 324 participants.
Also called NCT02022293
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 2
- Enrolled
- 324 participants
- Registry
-
NCT02022293
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Suspended
Technical summary
Registry record NCT02022293. Randomized; double masking; primary purpose prevention. Start 2017-01 (actual); primary completion 2023-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis
- Condition
- Nasopharyngeal Carcinoma
- Condition
- Radiation Therapy Complication
- Intervention (Drug)
- Atorvastatin
- Intervention (Other)
- Placebo
- Lead sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Record details
- Record id
cardio:ct-nct02022293- Content hash
8357d74ebc14f17a961aaa3c35111d43d925b610f458752bb45440d8243c1ec6